Diabetes mellitus and depression: Issues in theory and treatment

被引：15

作者：

Goodnick, PJ

机构：

[1] Mood Disorders Program, Dept. of Psychiat. and Behav. Sci., Univ. of Miami School of Medicine, Miami, FL

[2] Dept. Psychiat. and Behav. Sci., D79, 1400 NW 10 Ave., Miami

来源：

PSYCHIATRIC ANNALS | 1997年 / 27卷 / 05期

关键词：

D O I：

10.3928/0048-5713-19970501-11

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

[No abstract available]

引用

页码：353 / 359

页数：7

共 66 条

[1] INHIBITION OF INSULIN RELEASE BY SUBSTRATES AND INHIBITORS OF MONOAMINE-OXIDASE [J].

ALEYASSINE, H ;

LEE, SH .

AMERICAN JOURNAL OF PHYSIOLOGY, 1972, 222 (03) :565-+

[2]

American Psychiatric Press, 1987, DIAGNOSTIC STAT MANU

[3]

[Anonymous], 1994, DIAGNOSTIC STAT MANU

[4] NEW PHARMACOLOGICAL APPROACHES TO THERAPY OF NIDDM [J].

BRESSLER, R ;

JOHNSON, D .

DIABETES CARE, 1992, 15 (06) :792-805

[5] Are pharmacokinetic drug interactions with the SSRIs an issue? [J].

Brosen, K .

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :23-27

[6]

Cohen-Cole SA, 1993, PSYCHIAT CARE MED PA, P53

[7] A STUDY OF FLUOXETINE IN OBESE ELDERLY PATIENTS WITH TYPE-2 DIABETES [J].

CONNOLLY, VM ;

GALLAGHER, A ;

KESSON, CM .

DIABETIC MEDICINE, 1995, 12 (05) :416-418

[8]

COOPER AJ, 1964, LANCET, V1, P1133

[9] Mirtazapine - A review of its pharmacology and therapeutic potential in the management of major depression [J].

Davis, R ;

Wilde, MI .

CNS DRUGS, 1996, 5 (05) :389-402

[10]

DESPODOULOS A, 1991, COLOR ATLAS PHYSL

← 1 2 3 4 5 6 7 →